As you snack on turkey sandwiches and leftover pumpkin pie, check out the articles highlighted by the editors of the 10 AACR journals for the month of November. This month, the selected articles include...
The U.S. FDA approved a new combination of existing drugs to treat certain patients with multiple myeloma The U.S. Food and Drug Administration (FDA) approved a new combination therapy for multiple myeloma in adult...
A new drug approved by the U.S. FDA may help surgeons find cancer more easily and reduce the likelihood of leaving cancer cells behind The U.S. Food and Drug Administration (FDA) approved the imaging...
The U.S. FDA approved the first treatment for malignant perivascular epithelioid cell tumor The U.S. Food and Drug Administration (FDA) approved sirolimus protein-bound particles for injectable suspension (albumin-bound) (Fyarro) to treat adult patients with...
HPV vaccine rates are higher when teens decide, colorectal cancer is on the rise in people under 50, and other cancer research news of the week from Cancer Today magazine.
Study: Short-term, severe calorie restriction can reduce sugar and other substances in blood that may feed cancer cells and boost the antitumor immune response. A diet involving short-term, severe calorie restriction was safe and...
The FDA has approved an immunotherapy known as immune checkpoint inhibition for the treatment of certain patients with kidney cancer. The U.S. Food and Drug Administration (FDA) has approved the immunotherapeutic pembrolizumab (Keytruda) for...
The U.S. Is behind in preventing cervical cancer through HPV vaccination, and more cancer news of the week from Cancer Today magazine.
Every cell in the human body contains about 300 million base pairs of double-stranded DNA that contribute to a range of processes throughout the cell, including gene expression, metabolic regulation, tissue identity, and protein...
“Patient-centered” study seeks to assess quality of time that patients live by measuring the “treatment-free survival” outcome. A treatment combining two immunotherapies gave patients with advanced kidney cancer a longer time without subsequent treatment...
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More